Earlier this year pharmaphorum filmed a round table debate exploring how developments in personalised healthcare cancer treatments are defining the future for this area beyond oncology.
Scientists have developed a new test for a biomarker in brain tissue that could detect people who will go on to develop motor neuron disease (MND) before they show symptom